头孢他美酯治疗急性泌尿系统感染临床疗效分析

目的：分析头孢他美酯（cefetamet pivoxil）治疗急性泌尿系统感染的临床疗效。方法：20例急性泌尿系统感染患者随机分为两组，分别使用头孢他美酯和阿莫西林-克拉维酸钾片（奥格门，Augmemtin）治疗。A组：头孢他关酯治疗（n=10），每次250mg，早、晚饭后各服1次，B组：阿莫西林-克拉维酸钾片治疗（n=10），每次375mg，每日3次，饭后服用。两组疗程均为7d。对有效率、痊愈率，尿中白细胞清除率等方面进行评价。结果：两组治疗有效率分别为80％和90％：痊愈率分别为70％和80％；尿中白细胞的清除率分别为70％和80％。治疗中B组发生副反应1例。经统计分析，A、B两组间的药效及安全性无显著差异（P〉0．05）。结论：头孢他美酯是治疗急性泌尿系统感染的有效药物，值得，临床推广使用。

Analysis of clinical curative effects of cefetamet pivoxil on acute urinary system infected patients

Objective: To analyze the clinical curative effects of cefetamet pivoxil on acute urinary system infected patients. Meth-ods:20 acute urinary system infected patients were randomly divided into two groups: group A(n = 10), in which the patients were treated with cefetamet pivoxil(250mg, po, bid, pc) for 7 days, and group B(n = 10), in which the patients were administrated with amoxicillin-clavulante (375mg, po, tid, pc) for7days. The clinical effective rate, recovery rate and WBC clearance rate in urine were statistically evaluated. Results: The clinical effective rates of group A and group B were 80% and 90% , respectively. The recovery rates of group A and group B were 70% and 80% , respectively. The WBC clearance rates in urine of group A and group B were 70% and 80% , respectively. One side effect case occurred in group B. There was no significant difference statistically between two groups (P > 0.05). Conclusion: Cefetamet Pivoxil is efficient to treat acute urinary tract infection.